Springleaf Therapeutics

About:

SpringLeaf Therapeutics develops drug delivery technologies.

Website: http://www.springleaftx.com

Top Investors: Flybridge, GSK, North Bridge Venture Partners & Growth Equity, Excel Venture Management

Description:

SpringLeaf Therapeutics (formerly known as Entra Pharmaceuticals, Inc.) is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.